FDA Drug Application (021866) for ABILIFY by OTSUKA

Back to FDA Applications sponsored by OTSUKA

Application Number021866
Product Number001
FormINJECTABLE;INTRAMUSCULAR
Dosage9.75MG/1.3ML (7.5MG/ML)
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameABILIFY
Active IngredientARIPIPRAZOLE

Active IngredientCount
List of drugs with Active Ingredient ARIPIPRAZOLE3


Back to FDA Applications sponsored by OTSUKA